During the development of prostate cancer, cell survival depends primarily on the androgen receptor, as the decrease in the levels of these hormones is associated with a gradual transition from prostate cancer in a dependent to an androgen-independent manner, which it is more aggressive and difficult to treat [100]. The gene discussed is AR; the disease is prostate carcinoma.